Related Experiment Videos
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration
David Landman1, Elizabeth Babu, Neha Shah
1Division of Infectious Diseases, Department of Medicine, State University of New York-Downstate Medical Center, Brooklyn, New York, USA.
Objectives:
Carbapenem-resistant Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa are endemic in many medical centres. Because therapeutic options are limited, understanding the epidemiology and controlling the spread of these pathogens are of paramount importance.
Methods:
Isolates of K. pneumoniae, A. baumannii and P. aeruginosa were collected from 14 hospitals in New York City over a 3 month period in 2009, and analysed for the presence of genes encoding important carbapenemases. Comparisons were made with a similar study conducted in 2006. Demographic and infection control-related information from hospitals was collected.
Results:
Overall, 29% of K. pneumoniae possessed the carbapenemase KPC, significantly improved from the 38% observed in 2006 (P < 0.001). However, carbapenem resistance worsened in A. baumannii (mostly due to the emergence of strains with OXA-type carbapenemases) and P. aeruginosa. The decline in KPC-possessing K. pneumoniae was not uniformly observed in all of the hospitals. In a subset analysis of nine hospitals, those with a decreasing prevalence of bla(KPC) had shorter average lengths of stay.
Conclusions:
Measurable improvement has occurred in reducing the spread of KPC-possessing K. pneumoniae, and reducing the average length of stay may augment infection control efforts. However, the problem of carbapenem-resistant A. baumannii and P. aeruginosa lingers. New approaches, including respiratory isolation and environmental cleaning, need to be examined to control the spread of A. baumannii and P. aeruginosa.
Insights
Carbapenem-resistant Klebsiella pneumoniae rates decreased, but Acinetobacter baumannii and Pseudomonas aeruginosa resistance worsened. Shorter hospital stays may aid infection control for KPC- Klebsiella pneumoniae.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Carbapenem-resistant Gram-negative bacteria, including Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, pose significant challenges in healthcare settings due to limited treatment options.
- Understanding the epidemiology and controlling the transmission of these multidrug-resistant organisms (MDROs) is critical for patient safety and effective healthcare management.
Purpose of the Study:
- To assess the prevalence and trends of carbapenemase-producing K. pneumoniae, A. baumannii, and P. aeruginosa in New York City hospitals.
- To compare current resistance patterns with previous data and identify factors associated with changes in prevalence.
- To evaluate the impact of infection control measures on the spread of these resistant pathogens.
Main Methods:
- Collection of bacterial isolates (K. pneumoniae, A. baumannii, P. aeruginosa) from 14 New York City hospitals in 2009.
- Analysis of isolates for the presence of carbapenemase genes, including KPC and OXA types.
- Comparison with a similar study from 2006 and collection of hospital demographic and infection control data.
Main Results:
- A significant decrease in KPC-producing K. pneumoniae was observed (29% in 2009 vs. 38% in 2006, P < 0.001).
- Carbapenem resistance increased in A. baumannii and P. aeruginosa, primarily due to OXA-type carbapenemases.
- Hospitals with a declining prevalence of KPC-producing K. pneumoniae showed shorter average lengths of stay.
Conclusions:
- Progress has been made in reducing the spread of KPC-producing K. pneumoniae, with shorter hospital stays potentially contributing to infection control.
- The persistent challenge of carbapenem-resistant A. baumannii and P. aeruginosa necessitates further investigation.
- Novel infection control strategies, such as enhanced environmental cleaning and respiratory isolation, should be explored for A. baumannii and P. aeruginosa.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Acute Pyelonephritis II: Diagnostic Studies and Management